141 related articles for article (PubMed ID: 26792535)
1. Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study.
Huang F; Zhang H; Lv Q; Sato KD; Qu Y; Huan S; Cheng J; Zhao F; Wang L
Infect Dis Poverty; 2016 Jan; 5():2. PubMed ID: 26792535
[TBL] [Abstract][Full Text] [Related]
2. Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China.
Yuan L; Zhang H; Zhou C; Jiang W; Zhao Q; Biao X
BMC Infect Dis; 2017 Jan; 17(1):71. PubMed ID: 28086753
[TBL] [Abstract][Full Text] [Related]
3. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
Shen X; Li J; Gao Q; Xu B; Mei J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
[TBL] [Abstract][Full Text] [Related]
4. Doctors' compliance with national guidelines and clinical pathway on the treatment of tuberculosis inpatients in Hubei, China.
Zheng X; Zhong F; Zhang X
J Eval Clin Pract; 2014 Jun; 20(3):288-93. PubMed ID: 24690026
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
[TBL] [Abstract][Full Text] [Related]
6. Access to quality diagnosis and rational treatment for tuberculosis: real-world evidence from China-Gates Tuberculosis Control Project Phase III.
Li ZP; Mao WH; Huang F; Wang N; Ma LP; Zhang LQ; Gao MQ; Wang WB; Zhao Q; Tang SL
Infect Dis Poverty; 2021 Jun; 10(1):92. PubMed ID: 34187558
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.
Pang Y; Lu J; Huo F; Ma Y; Zhao L; Li Y; Liang Q; Chu N; Gao M; Huang H
J Infect; 2017 Nov; 75(5):433-440. PubMed ID: 28804028
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of extended treatment in pulmonary tuberculosis patients receiving first-line therapy and its association with recurrent tuberculosis in Beijing, China.
Xia Y; Goel S; Harries AD; Zhang Z; Gao T; Wang L; Cheng S; Lin Y; Du X
Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):402-7. PubMed ID: 24864048
[TBL] [Abstract][Full Text] [Related]
9. Errors in the treatment of tuberculosis in Baltimore.
Rao SN; Mookerjee AL; Obasanjo OO; Chaisson RE
Chest; 2000 Mar; 117(3):734-7. PubMed ID: 10712999
[TBL] [Abstract][Full Text] [Related]
10. Implementing a "free" tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world.
Jia X; Chen J; Zhang S; Dai B; Long Q; Tang S
Infect Dis Poverty; 2016 Jan; 5():1. PubMed ID: 26796785
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity and drug resistance of smear-positive pulmonary tuberculosis patients in the yi autonomous prefecture of China: a cross-sectional study.
Wang T; Zhou C; Shang L; Zhou X
BMC Infect Dis; 2023 Sep; 23(1):586. PubMed ID: 37674123
[TBL] [Abstract][Full Text] [Related]
12. Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China.
Wang N; Zhang H; Zhou Y; Jiang H; Dai B; Sun M; Li Y; Kinter A; Huang F
BMC Infect Dis; 2019 Oct; 19(1):844. PubMed ID: 31615433
[TBL] [Abstract][Full Text] [Related]
13. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
[TBL] [Abstract][Full Text] [Related]
14. Regional success on screening and chemoprophylaxis in contacts of patients with pulmonary tuberculosis in Turkey: a dispensary experience in 2016-2017.
Dundar C; Oztomurcuk D; Terzi O
Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):351-355. PubMed ID: 30892630
[TBL] [Abstract][Full Text] [Related]
15. The fourth national anti-tuberculosis drug resistance survey in Viet Nam.
Nhung NV; Hoa NB; Sy DN; Hennig CM; Dean AS
Int J Tuberc Lung Dis; 2015 Jun; 19(6):670-5. PubMed ID: 25946357
[TBL] [Abstract][Full Text] [Related]
16. Determining treatment outcome of smear-positive pulmonary tuberculosis cases in Afar Regional State, Ethiopia: A retrospective facility based study.
Tafess K; Mengistu B; Woldeyohannes D; Sisay S
Int J Mycobacteriol; 2016 Jun; 5(2):164-9. PubMed ID: 27242227
[TBL] [Abstract][Full Text] [Related]
17. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
[TBL] [Abstract][Full Text] [Related]
18. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China.
Li Q; Zhao G; Wu L; Lu M; Liu W; Wu Y; Wang L; Wang K; Qian HZ; Xie L
Antimicrob Resist Infect Control; 2018; 7():61. PubMed ID: 29744042
[TBL] [Abstract][Full Text] [Related]
20. [A cross-sectional study on economic burden of pulmonary tuberculosis cases from designated tuberculosis hospital].
Liu Y; Xu CH; Wang ZY; Wang XM; Wang YH; Zhang H; Wang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 May; 40(5):559-564. PubMed ID: 31177738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
